BERTOCCI DEREK A 4
4 · Guardant Health, Inc. · Filed Sep 3, 2020
Insider Transaction Report
Form 4
BERTOCCI DEREK A
Chief Financial Officer
Transactions
- Sale
COMMON STOCK
2020-09-01$94.33/sh−4,778$450,707→ 9,335 total - Sale
COMMON STOCK
2020-09-01$95.49/sh−2,902$277,120→ 6,433 total - Sale
COMMON STOCK
2020-09-01$96.08/sh−60$5,765→ 6,373 total - Sale
COMMON STOCK
2020-09-01$93.64/sh−22,360$2,093,862→ 14,113 total
Footnotes (4)
- [F1]These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- [F2]The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $93.05 to $94.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $94.06 to $95.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price.The shares were sold in multiple transactions at prices ranging from $95.08 to $96.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.